Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.

CORONARY ARTERY DISEASE, published by Lippincott Williams & Wilkins, stands as a vital contributor to the field of cardiology and cardiovascular medicine. Established in 1990, this esteemed journal presents cutting-edge research and insights from internationally recognized experts, facilitating the advancement of knowledge on coronary artery diseases. With its current impact factor placing it in the Q3 category for both Cardiology and Cardiovascular Medicine as well as miscellaneous Medicine, this journal is a valuable resource for researchers, healthcare professionals, and students alike, eager to stay abreast of developments in this critical area of health. Although it does not offer open access, articles published within its pages continue to influence clinical practice and healthcare strategies significantly. Situated at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, the journal engages a global audience, maintaining a commitment to showcasing innovative research until at least 2024. Engage with CORONARY ARTERY DISEASE to enhance your understanding and foster progress in cardiovascular health.

JACC: Cardiovascular Interventions is a premier journal dedicated to the field of cardiology and cardiovascular medicine, published by Elsevier Science Inc. This esteemed journal, with an ISSN of 1936-8798 and an E-ISSN of 1876-7605, has established itself as a leading platform for disseminating cutting-edge research and advancements from 2008 to the present, and is projected to continue until 2024. Recognized for its rigorous peer-review process and high-quality content, JACC: Cardiovascular Interventions holds a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine as well as a Q1 ranking in the broader category of Medicine (Miscellaneous) as of 2023. With a Scopus rank of #25 out of 387 in its field, placing it in the 93rd percentile, the journal is a vital resource for researchers, healthcare professionals, and students alike. Although it does not currently offer open access, its essential contributions to the medical community underscore its importance in advancing cardiovascular intervention knowledge and practice.

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

Journal of Cardiovascular and Thoracic Research is a premier open access journal published by Tabriz University of Medical Sciences & Health Services, focusing on the dynamic fields of cardiology and cardiovascular medicine. With an ISSN of 2008-5117 and E-ISSN 2008-6830, the journal provides a platform for innovative research and advances in cardiovascular and thoracic health, catering to a global audience of researchers, healthcare professionals, and students. Since its inception as an open access publication in 2010, the journal has established itself within the academic community, evidenced by its inclusion in Scopus and its category quartile ranking (Q3) in 2023. Located in Tabriz, Iran, the journal aims to disseminate high-quality studies that contribute to the understanding and treatment of cardiovascular diseases, thus enabling advancements in this critical field of medicine. With a Scopus rank of 248 out of 387 in the category of Cardiology and Cardiovascular Medicine, the Journal of Cardiovascular and Thoracic Research is dedicated to fostering collaboration and dialogue among researchers and practitioners, promoting a deeper understanding of cardiovascular and thoracic health.

SEMINARS IN INTERVENTIONAL RADIOLOGY, published by Thieme Medical Publishers Inc, is a pivotal peer-reviewed journal in the fields of interventional radiology, cardiology, and cardiovascular medicine. With a legacy spanning from 1984 to 2024, this journal serves as an essential resource for professionals seeking to advance their understanding of minimally invasive procedures and imaging techniques. Although it operates under a non-open access model, SEMINARS IN INTERVENTIONAL RADIOLOGY is committed to disseminating high-quality research and clinical insights, thus contributing to ongoing developments in effective medical practices. It enjoys a respectable position within the academic community, indicated by its 2023 rankings of Q3 in both cardiology and radiology categories, reflecting its relevance and influence in the respective fields. This journal not only addresses current trends and challenges but also aims to foster collaboration among researchers and clinicians, emphasizing the importance of evidence-based practices in improving patient outcomes.

Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.

Circulation-Cardiovascular Interventions, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier journal in the field of cardiology and cardiovascular medicine, recognized for its commitment to advancing the understanding and treatment of cardiovascular diseases. With a robust Impact Factor and ranking in the top 10% of its category, it serves as an essential resource for researchers, clinicians, and students seeking to stay at the forefront of cardiovascular intervention developments. This esteemed journal covers a range of topics, including innovative therapeutic strategies, cutting-edge clinical trials, and comprehensive reviews that inform clinical practice and influence guidelines. Since its inception in 2008, and extending through 2024, Circulation-Cardiovascular Interventions has published pivotal research that shapes the landscape of cardiovascular care in the United States and beyond. Its commitment to high-quality publications makes it an invaluable platform for sharing knowledge and fostering collaboration within the global medical community.

Cardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.